1776 results:
1651. Award for a Pioneer of Alzheimer’s Research  
British neuroscientist John Hardy will be awarded this year’s “Hartwig Piepenbrock-DZNE Prize” which is endowed with 60,000 Euro. Piepenbrock and the DZNE herewith honor his seminal contributions to…  
1652. MetLife Foundation Award: Munich-based DZNE researcher receives coveted US prize for medical research  
Professor Christian Haass, site speaker at the DZNE in Munich, yesterday has been honored by MetLife Foundation in the USA at the Alzheimer’s Association International Conference in Washington DC.…  
1653. DZNE researcher becomes scientific leader of team developing national expert standard on "Nursing Care for People with Dementia"  
The number of people in Germany who require nursing care has been rising steadily for years. Demographic developments indicate that this trend will continue. A parallel increase in the number of…  
1654. Diabetes medication reduces dementia risk  
Treating people with type 2 diabetes, also known as "age-related diabetes" with antidiabetics reduces their risk for Alzheimer’s and other types of dementia. The risk is most significantly reduced by…  
1655. DZNE Researchers find speedometer in the brain  
Researchers in Bonn have identified neural circuits in the brains of mice that are pivotal for movement and navigation in space. These nerve cells that are presumed to exist in a similar form in…  
1656. Fruit fly studies shed light on adaptability of nerve cells  
An international team of researchers at DZNE and Tokyo Tech have revealed in a collaborative study - published today in Neuron, that neurons in the eye change on the molecular level when they are…  
1657. Germany’s one-of-a-kind concept aiming to improve the at home medical care for dementia patients delivers first results  
Yesterday, the participating scientists from DZNE, the Institute for Community Medicine at the University of Greifswald’s Medical Faculty and family practitioners discussed the status of the study…  
1658. University of Wisconsin-Madison and DZNE Agree to Collaborate on Alzheimer’s, Dementia Research  
Officials of both institutions today agreed to collaborate on research efforts with the potential to improve outcomes for patients with neurodegenerative disease and for individuals at increased risk…  
1659. Regeneration in a hostile environment - Cancer drug promotes regeneration of damaged neurons.  
DZNE researchers show in Science: Cancer drug epothilone promotes neuronal regeneration and improves motor skills after experimental spinal cord injury. Cancer drug promotes regeneration of damaged…  
1660. Dr. Sabine Helling-Moegen is the new Administrative Director of the German Center for Neurodegenerative Diseases  
Together with Professor Pierluigi Nicotera, Chairman of the Executive Board and Scientific Director, Helling-Moegen leads the research institute with more than 800 employees spread across nine sites…  
Search results 1651 until 1660 of 1776